Clinical Trial Update: Immunogenicity and Safety Trial of the HIV-1 Tat Vaccine [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the immunogenicity and safety of the HIV-1 Tat vaccine, reporting immune responses and safety observations in individuals with HIV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• HIV-1 Tat vaccine (Tat vaccine)

Snippet

Sponsor: Barbara Ensoli, MD | Conditions: HIV Infections | Phase 2 | Status: COMPLETED